Tiglutik 50 mg in 10 mL Oral Suspension
RxNorm 2059266
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2059266 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Tiglutik 50 mg in 10 mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Riluzole 5 mg/ML Oral Suspension [Tiglutik]
(Atom ID: 12357493)
SYPrescribable
Synonym (SY):
Tiglutik 25 mg per 5 mL Oral Suspension
(Atom ID: 10782980)
SYPrescribable
Synonym (SY):
Tiglutik 5 mg/ML Oral Suspension
(Atom ID: 10338813)
PSNPrescribable
Prescribable Name (PSN):
Tiglutik 50 mg in 10 mL Oral Suspension
(Atom ID: 12759477)
SYPrescribable
Synonym (SY):
Tiglutik 50 mg per 10 mL Oral Suspension
(Atom ID: 10338815)
Patient Education
Riluzole
Riluzole is used to treat amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease). Riluzole is in a class of medications called benzothiazoles. It works by changing the activity of certain natural substances in the body that affect nerves and muscles.
[Learn More]
* Please review the disclaimer below.